tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD
US Market

Opus Genetics (IRD) Income Statement

Compare
1,235 Followers

Opus Genetics Income Statement

Last quarter (Q3 2025), Opus Genetics's total revenue was $3.08M, a decrease of -20.38% from the same quarter last year. In Q3, Opus Genetics's net income was $-17.45M. See Opus Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.99M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Gross Profit
$ 10.99M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Operating Expenses
$ 73.07M$ 29.61M$ 21.62M$ 23.29M$ 19.97M
Depreciation and Amortization
$ 10.00K$ 6.00K$ 4.00K$ 4.00K$ 8.00K
EBITDA
$ -57.52M$ -9.97M$ 18.22M$ -56.69M$ -17.77M
Operating Income
$ -62.07M$ -10.56M$ 18.23M$ -22.70M$ -19.97M
Other Income/Expenses
$ 4.54M$ 589.00K$ -23.00K$ -33.99M$ -4.65M
Pretax Income
$ -57.53M$ -9.97M$ 18.20M$ -56.69M$ -24.62M
Net Income
$ -57.53M$ -9.99M$ 17.89M$ -56.69M$ -24.62M
Per Share Metrics
Basic EPS
$ -2.15$ -0.46$ 0.90$ -3.82$ -5.28
Diluted EPS
$ -2.15$ -0.46$ 0.87$ -3.82$ -5.28
Weighted Average Shares Outstanding
26.72M 21.59M 19.93M 14.85M 4.66M
Weighted Average Shares Outstanding (Diluted)
26.72M 21.59M 20.60M 14.85M 4.66M
Currency in USD

Opus Genetics Earnings and Revenue History